Literature DB >> 12824226

A statistical model for the evaluation of sensory tests in glaucoma, depending on optic disc damage.

Andrea Stroux1, Matthias Korth, Anselm Jünemann, Jost B Jonas, Folkert Horn, Andreas Ziegler, Peter Martus.   

Abstract

PURPOSE: To analyze the sensitivity of various sensory tests adjusted for glaucomatous optic disc damage.
METHODS: In a cross-sectional study, the results of testing of 196 control subjects (age range, 18-69 years) and 308 patients with chronic open-angle glaucoma (age range, 18-70 years) were included. The perimetric mean defect (MD), a temporal contrast sensitivity test (TCS), a spatiotemporal contrast sensitivity test (STCS), the peak time of a blue-on-yellow visual evoked potential (BYVEP), and the amplitude of a pattern-reversal electroretinogram (PERG) were evaluated by a specific logistic regression model. This model included glaucomatous damage, quantified by neuroretinal rim area corrected for disc size, as a covariate of sensitivity.
RESULTS: Sensitivity of diagnostic tests increased for all procedures with increasing loss of neuroretinal rim area. With progressing optic disc damage, MD and STCS showed higher sensitivity than did TCS. BYVEP showed a higher sensitivity than PERG in all disease stages. In general, the psychophysical tests were more sensitive than the electrophysiological ones.
CONCLUSIONS: The specific model used in this study was an appropriate tool to analyze the sensitivity of several sensory glaucoma tests in relation to disease stage. Moreover, tests that were more sensitive in early disease stages (TCS) and others that were more sensitive in more advanced stages (MD, STCS) were identified.

Entities:  

Mesh:

Year:  2003        PMID: 12824226     DOI: 10.1167/iovs.02-0419

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  2 in total

1.  Effect of disease severity on the performance of Cirrus spectral-domain OCT for glaucoma diagnosis.

Authors:  Mauro T Leite; Linda M Zangwill; Robert N Weinreb; Harsha L Rao; Luciana M Alencar; Pamela A Sample; Felipe A Medeiros
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-24       Impact factor: 4.799

2.  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

Authors:  Vincenzo Parisi
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.